Study on the combined scheme of Quxie Capsule in the third-line treatment of metastatic colorectal cancer and the characteristics of the dominant population
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Interventions: Treatment group:Quxie capsule + Furaquitinib + Regofini + TAS-102;control group:Furaquitinib + Regofini + TAS-102 Primary outcome(s): overall survival (OS) Study Design: Non randomized control
创建时间：
2022-08-15
